About this trial
A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) to enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Infants born with gestational age > 35 weeks.
Birth weight ≥ 1800 grams
Age 1 - 14 days
Infants requiring a TSB blood sample for clinically suspected jaundice as part of standard care
Disqualifiers
Infants showing signs of inborn disease.
Infants with skin rash or other skin disease that affects the skin where measurements are performed.
Infants transferred to the pediatric ward for medical treatment.
Infants that have received phototherapy in the last 24 hours
Trial design
Single group
Treatments tested in this trial
Picterus Jaundice Pro (JP)
DeviceUse Picterus Jaundice Pro, a smartphone app that is used to take photo of the newborns skin, where the Picterus calibration card is place.
Treatment groups
Trial outcomes
Primary outcomes
Enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.
Evaluate of smartphone-based screening tool (Picterus JP) for neonatal jaundice in newborns with high melanin content.
Secondary outcomes
Adapt the current algorithm of Picterus JP to newborns with high melanin content in the skin.
Adapt the current algorithm of Picterus JP to newborns with high melanin content in the skin.
Correlate estimates of bilirubin levels obtained by Picterus JP with TSB, TcB and VA in newborns with high melanin content in the skin.
Correlate estimates of bilirubin levels obtained by Picterus JP with TSB, TcB and VA in newborns with high melanin content in the skin.
Determine the accuracy of Picterus JP in newborns with high melanin content in the skin.
Determine the accuracy of Picterus JP in newborns with high melanin content in the skin.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Picterus AS
Lead sponsor
University of Chicago
Collaborator